Glam girl Heddy Lamar may have used her good looks to good effect on the silver screen, but she put her smarts to better use as an inventor. During World War II, she co-patented a frequency-switching system for torpedo guidance that was considered years ahead of its time.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7034034 | Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives capable of modulating NPY5 receptor activity, are provided. Such compounds may be used to modulate NPY binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety... | 04/25/2006 |
| 6878734 | Gastrin and cholecystokinin receptor ligands(II) Ligands for the gastrin and cholecystokinin (CCK) receptors are provided, together with methods for preparing such ligands, and compounds which are useful intermediates in such methods. Pharmaceutical compositions comprising such ligands, methods for preparing such ... | 04/12/2005 |
| 6794405 | Alicyclic imidazoles as H3 agents Alicyclic imidazole compounds; pharmaceutically active compositions containing such compounds; and the use of such compounds in formulations for the control or prevention of disease states in which histamine H3 receptors are involved, such as allergy, inf... | 09/21/2004 |
| 6603019 | 1-imidazolyl substituted tetrahydronaphthalene derivatives as inhibitors of eytochrome P450RAI Compounds having Formula 4 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids ##STR1##... | 08/05/2003 |
| 6525082 | Apoptosis inducer A substance for inducing apoptosis represented by specific formulae. A pharmaceutical composition which can be used for an anticancer agent containing said substance.... | 02/25/2003 |
| 6518305 | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases Disclosed are compounds of the formula: ##STR1## which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caus... | 02/11/2003 |
| 6479530 | Imidazole derivatives having affinity for 댒 receptors Imidazole derivatives of formula I ##STR1## wherein n is 0 or 1, R1 is hydrogen or C1 -C4 -alkyl, R2 is hydrogen or R2 and R3 together form a double bond, R3 is hydrogen or C | 11/12/2002 |
| 6426360 | 4,5-substituted imidazolyl compounds for the treatment of inflammation A class of compounds is described for treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula ##STR1## wherein R1 is selected from lower alkyl, lower haloalkyl, lower hydroxyalkyl, ... | 07/30/2002 |
| 6417218 | Substituted imidazoles, their preparation and use A class of substituted imidazole compounds of formula I ##STR1## methods for their preparation, pharmaceutical compositions comprising them and use thereof in the treatment of disorders related to the histamine H3 receptor are disclosed. More particularly... | 07/09/2002 |
| 6362211 | Polycyclic indanylimidazoles with alpha2 adrenergic activity A compound of formula I ##STR1## wherein R1 to R3, --A--, m and t are as defined in claim 1, or a pharmaceutically acceptable salt or ester thereof, useful as an alpha2 adrenergic agent.... | 03/26/2002 |
| 6316380 | Catalyst system comprising transition metal and imidazoline-2-ylidene or imidazolidine-2-ylidene This invention provides a catalyst system useful in many coupling reactions, such as Suzuki, Kumada, Heck, and amination reactions. The catalyst system of the present invention makes use of N-heterocyclic carbenes or their protonated salts. The compositio... | 11/13/2001 |
| 6313311 | Imidazole derivatives having affinity for alpha2 receptors Imidazole derivatives of formula (I) ##STR1## wherein n is 0 or 1, R1 is hydrogen or C1 -C4 -alkyl, R2 is hydrogen or R2 and R3 together form a double bond, R3 is hydrogen or C | 11/06/2001 |
| 6177575 | Process for manufacture of imidazoles Imidazoles may be manufactured by reacting a glyoxal, ammonia, an aldehyde, and optionally a primary amine, in the presence of a Bronsted acid whose pKa is approximately equal to the pKa of the ammonium cation of the primary amine, or if the primary amine... | 01/23/2001 |
| 6124465 | Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments Novel products of formula (I), their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments. ##STR1## In the formula (I), the following substituents are among the preferred: Ar represents ... | 09/26/2000 |
| 6121273 | N-linked sulfonamides of heterocyclic thioesters This invention relates to neurotrophic low molecular weight, small molecule N-linked sulfonamides of heterocyclic thioesters having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin pr... | 09/19/2000 |
| 6013662 | Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments Novel products of formula (I), their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments. ##STR1## In the formula (I), the following substituents are among the preferred: Ar represents ... | 01/11/2000 |
| 6008240 | 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives The present invention provides compounds having H3 histamine receptor antagonist activity of the general formula: ##STR1## R2 is a hydrogen or a methyl or ethyl group; R3 is a hydrogen or a methyl or ethyl group; n is... | 12/28/1999 |
| 5990317 | 2-(1H-4(5)-imidazoyl) cyclopropyl compounds The present invention provides compounds having H3 histamine receptor antagonist activity of formula (1.0) wherein R2 is a hydrogen or a methyl or ethyl group; R3 is a hydrogen or a methyl or ethyl group; n is 0, 1, 2, 3, ... | 11/23/1999 |
| 5977377 | Process for producing N-alkylimidazole Disclosed is a process for producing an N-alkylimidazole which comprises reacting an imidazole with an N-alkylating agent in an organic solvent in the presence of alkali particles having a specific surface area of 0.6 M2 /g or larger.... | 11/02/1999 |
| 5877326 | Aqueous phase process for preparing N-substituted imidazoles A process for preparing substituted imidazoles of the formula I ##STR1## R1, R2 and R3 are identical or different and are each hydrogen, halogen, NO2, CN or a C1 -C20 -hydrocarbon radi... | 03/02/1999 |
| 5719291 | Cyclohexane derivatives Compounds of the formula ##STR1## which have antifungal activity.... | 02/17/1998 |
| 5658938 | Substituted 1H-imidazoles Substituted 4-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazoles and 4-(2,3-dihydro-1H-inden-1-yl)-1H-imidazoles, their optical isomers and their racemic mixtures, their salts, methods for preparing them and therapeutic compositions containing them. These ... | 08/19/1997 |
| 5652258 | 2-(4-imidazoyl) cyclopropyl derivatives The present invention provides compounds having H3 histamine receptor antagonist activity of the general formula: ##STR1## where X is H, A is --CH2 CH2 --, --COCH2 --, --CONH--, --CON(CH3)--, --C... | 07/29/1997 |
| 5646293 | Preparation of N-alkenylazoles A process for preparing N-alkenylazoles of the general formula I ##STR1## where X is CH--R6 or nitrogen, R1 and R2 are hydrogen or C1 - to C8 -alkyl, R3,R4,R5 and R6 | 07/08/1997 |
| 5620999 | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation A class of imidazolyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II ##STR1## wherein R1 is selected from lower alkyl, lower haloalkyl,... | 04/15/1997 |
| 5366984 | Methyl -arylacrylates substituted by a heterocyclic radical and their use Methyl -arylacrylates substituted by a heterocyclic radical and having the general formula ##STR1## where R is alkyl, alkenyl, haloalkyl, cycloalkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, halogen or aryl, the aromatic ring being unsubstituted... | 11/22/1994 |
| 5312927 | Preparation of imidazoles The present invention relates to preparation of imidazoles which are useful as pharmaceutical and agricultural chemicals. Specifically, the present invention relates to a process for preparing imidazoles of the formula (I): ##STR1## which compri... | 05/17/1994 |
| 5292887 | Substituted imidazole derivatives and their preparation and use Compounds of the formula: ##STR1## wherein X is --CH2 -- or ##STR2## R1 is H, C1-5 -alkyl or benzyl, which can be substituted or unsubstituted R2 is H, C1-4 -alkyl, OH or C1-3 -al... | 03/08/1994 |
| 5233048 | Triarylmethane color formers Color formers of the general formula ##STR1## in which --independently of one another-- R1 and R2 are hydrogen, halogen, alkyl, aralkyl etc., Y1 and Y2 are alkyl, aryl, cycloalkyl or aralkyl, X1 is al... | 08/03/1993 |
| 5227401 | Ethynyl alanine amino diol compounds for treatment of hypertension Compounds characterized generally as ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are those of Formula I ##STR1## wherein A is selected from CO and SO2 | 07/13/1993 |
| 5225548 | Indophenol dyes and thermal transfer thereof Indophenol dyes of the formula ##STR1## where X is nitrogen or the radical CH, Q is a five-membered heterocyclic radical, and K is a radical of an aniline, aminonaphthalene, aminoquinoline or aminothiazole derivative, and the radical A can be benzofused, ... | 07/06/1993 |
| 5207816 | Cyclohexenone derivatives and their use for controlling undesirable plant growth Cyclohexenone derivatives of the formula ##STR1## where R1 is alkyl, R2 is alkyl, unsubstituted or halogen-substituted alkenyl or alkynyl, X is a substituted or unsubstituted five-membered heteroaromatic radical, and Z is hydrog... | 05/04/1993 |
| 5204364 | N-imidazolyl- and N-imidazolylmethyl-derivatives of substituted bicyclic compounds The present invention relates to new N-imidazolyl and N-imidazolylmethyl derivatives of bicyclic compounds having the general formula (I) ##STR1## Wherein A is a ࣙCR3 or >CHR3 group, in which R3 is hydrogen or C | 04/20/1993 |
| 5194623 | Azlactone based photographic reagents Novel compounds derived from azlactones act as precursors for photographically active groups. The active groups are released at an appropriate time in the use of photographic and photothermographic systems.... | 03/16/1993 |
| 5191086 | Imidazole and benzimidazole derivatives Novel angiotensin-II receptor antagonists are disclosed having the general formula ##STR1## wherein R1, R2, R3, R4, R5, W and X are as defined herein.... | 03/02/1993 |
| 5190942 | Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives Novel compounds are disclosed having the formula ##STR1## wherein X, Y, R1, R2, R3, R4, and R5 are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefor... | 03/02/1993 |
| 5179210 | Preparation of N-substituted imidazoles A process for preparing N-substituted imidazoles of the formula I ##STR1## where R1 is C1 -C20 -alkyl, C2 -C20 -alkenyl, C2 -C20 -alkynyl, C2 -C20 -alkoxyal... | 01/12/1993 |
| 5177099 | Dichloro-substituted imidazole derivatives as antifungal agents Dichloro-substituted 1-(5H-dibenzo[a,d]cyclohepten-5-yl)-1H-imidazole comnds of formula (I), in which --X-- is either --CH2 --CH2 -- or --CH.dbd.CH--, and their pharmaceutically acceptable addition salts, preferably the nitric acid ... | 01/05/1993 |
| 5175151 | Antiviral compounds and antihypertensive compounds Compounds useful as antihypertensive agents, or antiviral agents against DNA containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by Formula 1.0: ##STR1## and their pharmaceutically acceptable salts and solva... | 12/29/1992 |
| 5162541 | Transfer hydrogenolysis of alkylheteroaryl halo-containing compounds A method for dehalogenating a compound of the generalized structure ##STR1## is disclosed where: R1, R2 and R3 independently are hydrogen or methyl or R1 and R3 taken together represent methylene... | 11/10/1992 |